Who owns BRIACELL THERAPEUTICS CORP?

Tip: Access positions for across all investors

Analyze quarterly positions in Briacell Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Briacell Therapeutics Corp stock

Who bought or sold BRIACELL THERAPEUTICS CORP this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Citadel Advisors 11k $122k 100% Sep 2025
 View chart
Flagship Harbor Advisors 4.0k $28k 100% Dec 2025
 View chart
Federation des caisses Desjardins du Quebec 1.2k $8.6k 33% Dec 2025
 View chart
UBS Group 638.00 $4.5k 897% Dec 2025
 View chart
Royal Bank of Canada 100.00 $1.0k 100% Sep 2025
 View chart
Hanson McClain Advisors 100.00 $711.000000 1329% Dec 2025
 View chart
Group One Trading 70.00 $498.001000 0% Dec 2025
 View chart
Ssa Swiss Advisors 37.00 $263.998700 100% Dec 2025
 View chart
TD Waterhouse Canada 19.00 $135.000700 0% Dec 2025
 View chart
FNY Investment Advisers 10.00 $0 0% Dec 2025
 View chart
Tower Research Capital 9.00 $63.999900 100% Dec 2025
 View chart
HHM Wealth Advisors 6.00 $43.000200 0% Dec 2025
 View chart
Wells Fargo & Company 1.00 $7.000000 0% Dec 2025
 View chart

Who sold out of Briacell Therapeutics Corp?

Fund or Company Name Date Sold Shares Held Valued At
SBI Securities Sep 2025 80.00 $880.000000
Advisor Group Holdings Sep 2025 6.00 $46.000200